Conor Meehan
Understanding how pathogens transmit between hosts and the underlying genomic mechanisms that confer resistance to drugs is crucial for reducing the incidence of infection and increasing the effectiveness of treatments.
Dr. Meehan's research focusses on the evolution and epidemiology of microbes, primarily pathogenic mycobacteria such as M. tuberculosis, M. ulcerans and M. leprae. His primary goal is to enhance incorporation of molecular techniques into clinical and public health settings for tracking drug resistance and pathogen transmission in high burden settings, with an emphasis on whole genome sequencing coupled with phylogenetics-based analyses.